Carol Gallagher - Jun 23, 2022 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Role: Director
Signature: /s/ David Tucker, Attorney-in-Fact
Stock symbol: ATRA
Transactions as of: Jun 23, 2022
Transactions value $: $0
Form type: 4
Date filed: 6/27/2022, 04:48 PM
Previous filing: Jun 16, 2021
Next filing: Aug 17, 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ATRA	Common Stock	Award	$0	+20.5K	+18.32%	$0.00	132K	Jun 23, 2022	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ATRA	Non-Qualified Stock Option (Right to Buy)	Award	$0	+31.5K		$0.00	31.5K	Jun 23, 2022	Common Stock	31.5K	$7.35	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These restricted stock units shall vest on the earlier of June 23, 2023 or the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service.
F2	The amount of securities beneficially owned by the reporting person shown here corrects an inadvertent understatement of 100 shares in a prior Form 4.
F3	The option shall vest on the earlier of June 23, 2023 or the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service.